Cargando…

RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma

The ribophorin family (RPN) is an essential regulatory subunit of the proteasome. By influencing the ubiquitin-proteasome system activity, ribophorins (RPNs) are responsible for almost all physiology and pathology processes of mammalian cells. Nevertheless, little is known about the role of RPNs in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Wangyang, Zheng, Yuling, Bai, Xue, Zhou, Yongxu, Yu, Liang, Ji, Daolin, Leng, Kaiming, Meng, Nanfeng, Wang, Hang, Huang, ZiYue, Xu, Yi, Cui, Yunfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444382/ https://www.ncbi.nlm.nih.gov/pubmed/36072976 http://dx.doi.org/10.1155/2022/7270541

Ejemplares similares

Transcriptional ITPR3 as potential targets and biomarkers for human pancreatic cancer
por: Zheng, Wangyang, et al.
Publicado: (2022)

Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment
por: Wang, Hang, et al.
Publicado: (2022)

Deoxyelephantopin induces apoptosis via oxidative stress and enhances gemcitabine sensitivity in vitro and in vivo through targeting the NF-κB signaling pathway in pancreatic cancer
por: Ji, Daolin, et al.
Publicado: (2020)

NcRNAs and Cholangiocarcinoma
por: Wangyang, Zheng, et al.
Publicado: (2018)

YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2
por: Li, Jinglin, et al.
Publicado: (2022)

Huaier Restrains Cholangiocarcinoma Progression in vitro and in vivo Through Modulating lncRNA TP73-AS1 and Inducing Oxidative Stress
por: Ji, Daolin, et al.
Publicado: (2020)

Up‐regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR‐296‐5p
por: Li, Zhenglong, et al.
Publicado: (2019)

Extracellular Vesicles Act as Carriers for Cargo Delivery and Regulate Wnt Signaling in the Hepatocellular Carcinoma Tumor Microenvironment
por: He, Risheng, et al.
Publicado: (2023)

Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review
por: Zhao, Xudong, et al.
Publicado: (2023)

Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma
por: Huang, Lining, et al.
Publicado: (2019)

SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN
por: Li, Jinglin, et al.
Publicado: (2020)

G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
por: Wang, Hang, et al.
Publicado: (2022)

The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma
por: Xu, Yi, et al.
Publicado: (2017)

Retraction: The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma
por: Xu, Yi, et al.
Publicado: (2023)

Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
por: Mínguez, Beatriz, et al.
Publicado: (2011)

Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma
por: Huang, Ziyue, et al.
Publicado: (2023)

SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma
por: Xu, Yi, et al.
Publicado: (2018)

Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma
por: Yu, Heng, et al.
Publicado: (2022)

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

Identification of afatinib-associated ADH1B and potential small-molecule drugs targeting ADH1B for hepatocellular carcinoma
por: Zhou, Yongxu, et al.
Publicado: (2023)

S100 Proteins as Diagnostic and Prognostic Markers in Colorectal and Hepatocellular Carcinoma
por: Maletzki, Claudia, et al.
Publicado: (2012)

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021)

Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma
por: Lu, Chang-Yi, et al.
Publicado: (2016)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Long non-coding RNA MIAT in development and disease: a new player in an old game
por: Sun, Cheng, et al.
Publicado: (2018)

Circ_ASPH promotes cholangiocarcinoma growth and metastasis through the miR‐581/ATP‐binding cassette transporter G1 signaling pathway
por: Xu, Yi, et al.
Publicado: (2020)

Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma
por: You, Junqi, et al.
Publicado: (2023)

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
por: Xia, Haoming, et al.
Publicado: (2022)

Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway
por: Leng, Kaiming, et al.
Publicado: (2019)

CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis
por: Deng, Hongyang, et al.
Publicado: (2022)

Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma
por: He, Jingyi, et al.
Publicado: (2020)

Binding pancreaticogastrostomy anastomosis in central pancreatectomy: A single center experience
por: Kang, Pengcheng, et al.
Publicado: (2017)

Long non-coding RNA UCA1 indicates an unfavorable prognosis and promotes tumorigenesis via regulating AKT/GSK-3β signaling pathway in cholangiocarcinoma
por: Xu, Yi, et al.
Publicado: (2017)

Corrigendum: CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis
por: Deng, Hongyang, et al.
Publicado: (2023)

Increased Expression of Cathepsin L: A Novel Independent Prognostic Marker of Worse Outcome in Hepatocellular Carcinoma Patients
por: Ruan, Jian, et al.
Publicado: (2014)

Progress on diagnostic and prognostic markers of pancreatic cancer
por: YANG, HONG, et al.
Publicado: (2023)

Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma
por: Bai, Hansong, et al.
Publicado: (2019)

Comprehensive Analysis of HOX Family Members as Novel Diagnostic and Prognostic Markers for Hepatocellular Carcinoma
por: Jin, Zhipeng, et al.
Publicado: (2022)

Common Sensitive Diagnostic and Prognostic Markers in Hepatocellular Carcinoma and Their Clinical Significance: A Review
por: Samman, Basim Saleh, et al.
Publicado: (2022)

NRAGE is a potential diagnostic biomarker of hepatocellular carcinoma
por: Zou, Wenshuang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5h3ib0857ptvp07649l63e3oos